Much of the effort in converting biomass to biobased chemicals has been driven by the retrosynthesis of target molecules. An alternative approach is the synthesis of “bioprivileged molecules” that are biology-derived chemical species that can be readily converted to a diversity of chemical products including drop-in replacements and novel species. Bioprivileged molecules will be an industry game changer used for next generation materials, specialty chemicals, nutraceuticals, antimicrobials, insecticides, herbicides, consumer goods, and much more.
Join Brent Shanks and Peter Keeling of the NSF Engineering Research Center for Biorenewable Chemicals at Iowa State University as they prove that the diverse-bioproduct potentiality of a bioprivileged molecule is vital in creating value from biomass. Discover during this free interactive broadcast how and why innovative bioproducts represent a powerful driver for the development of biobased chemicals beyond just replacing fossil carbon with renewable carbon.
What You Will Learn
- What are some real life examples of bioprivileged molecules
- How can bioprivileged be conceptualized and accessed
- How bioprivileged molecules can help enable biobased chemical development and commercialization
Co-Producer
The Fine Print
ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.
;void(0);){kind=link}